Heparin Sodium Injection recall: Labeling Error
Heparin Sodium Injection, USP, 20,000 USP units per mL, 25 x 1 mL Multi-Dose Vials, Rx Only, For Intravenous or Subcutaneous Use, Mfd. for: Sagent…
Why was Heparin Sodium Injection recalled?
Labeling: Not elsewhere classified
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot#: WP201, Exp 2/2024
- Product
- Heparin Sodium Injection, USP, 20,000 USP units per mL, 25 x 1 mL Multi-Dose Vials, Rx Only, For Intravenous or Subcutaneous Use, Mfd. for: Sagent…
- Recalling firm
- Sagent Pharmaceuticals Inc
- Quantity
- 28,875 vials
- Distribution
- USA Nationwide
- Recall date
- March 15, 2023
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)